News

FDA Clears AI Software for Brain Aneurysm Detection

The U.S. Food and Drug Administration has cleared artificial intelligence software designed to support brain aneurysm detection. The clearance gives radiology professionals a new AI-assisted tool for identifying a potentially serious condition on medical images.

The announcement marks a further step in the adoption of AI in medical imaging, where software can assist clinicians with detection and assessment. Details on the software’s technical methods, performance, and intended workflow were not included in the source material.

Sources